TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $98K of Entrada Therapeutics, Inc.
Sold$97,892
$12.25Price
7,988Shares
−5%Stake
What TRDA did after the filing
- The stock from Fri, Mar 6 close, $12.58
- +7.8%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Apr 20 close.
Traded Wed, Mar 4. Filed Fri, Mar 6, 11:36 AM ET, during the session. Returns use the Mar 6 close and the Apr 20 close. Not investment advice.